FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:543-545 August 10, 2006 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

With a credit card and a few clicks of their computer mouse, consumers can now order a test for the BRCA1 or BRCA2 gene mutation or any of hundreds of other diagnostic assays, all without involving their physician or health insurance plan. Direct-to-consumer marketing of genetic testing and other laboratory services has arrived.

Proponents argue that the companies offering these tests are bringing sophisticated diagnostic services to consumers who are interested in genetic testing and have the money to pay for it but lack access to clinical testing sites. And they laud the companies' promise of anonymity to consumers who . . . [Full Text of this Article]

Source Information

Dr. Wolfberg is a fellow in maternal fetal medicine at Tufts–New England Medical Center, Boston.

This article has been cited by other articles:

• Cheng, T. L., Cohn, R. D., Dover, G. J. (2008). The Genetics Revolution and Primary Care Pediatrics. JAMA 299: 451-453 [Full Text]  
• Fatouros, M., Baltoyiannis, G., Roukos, D. H. (2008). The Predominant Role of Surgery in the Prevention and New Trends in the Surgical Treatment of Women With BRCA1/2 Mutations. Ann. Surg. Oncol. 15: 21-33 [Abstract] [Full Text]  
• Judge, D. P., Johnson, N. M., Cirino, A. L., Ho, C. Y. (2007). Heart Failure and Genomics. J Am Coll Cardiol 49: 1106-1106 [Full Text]